Centennial Wealth Advisory’s Gilead Sciences GILD Stock Holding History

Centennial Wealth Advisory’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209K	Buy	+1,656	New	+$218K	0.05%	175
2023 Q2	–	Sell	-6,489	Closed	-$538K	–	131
2023 Q1	$538K	Buy	6,489 +281	+5%	+$23.3K	0.29%	55
2022 Q4	$533K	Sell	6,208 -151	-2%	-$12K	0.3%	50
2022 Q3	$392K	Buy	+6,359	New	+$401K	0.23%	52

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Centennial Wealth Advisory's GILD Position: Q2 2026 in Review

Centennial Wealth Advisory opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,656 shares worth $209K. The stake represents 0.05% of the portfolio and ranks #175 among its holdings. This is a return to the name: Centennial Wealth Advisory previously reported a position in GILD as recently as Q1 2023.

Centennial Wealth Advisory first reported a position in GILD in Q3 2022 and has held it in 4 quarters since. The position peaked at $538K in Q1 2023. 370 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Centennial Wealth Advisory held 1,656 shares of Gilead Sciences worth $209K as of Q2 2026.
Gilead Sciences was a new Centennial Wealth Advisory position in Q2 2026.
Gilead Sciences made up 0.05% of Centennial Wealth Advisory's portfolio in Q2 2026, its #175 holding.
Centennial Wealth Advisory first reported a position in Gilead Sciences in Q3 2022 and has held it in 4 quarters since.
Centennial Wealth Advisory's Gilead Sciences position peaked at $538K in Q1 2023.
370 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Centennial Wealth Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.